Anzeige
Mehr »
Samstag, 10.01.2026 - Börsentäglich über 12.000 News
Fundamental stark, Kurs zu niedrig - Chance beim Krebs-Impfstoff-Pionier!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A14M4J | ISIN: KYG548721177 | Ticker-Symbol: 81X
Frankfurt
09.01.26 | 17:46
0,173 Euro
+4,85 % +0,008
Branche
Gesundheitswesen
Aktienmarkt
ASIEN
1-Jahres-Chart
LIFETECH SCIENTIFIC CORPORATION Chart 1 Jahr
5-Tage-Chart
LIFETECH SCIENTIFIC CORPORATION 5-Tage-Chart
RealtimeGeldBriefZeit
0,1740,19309.01.

Aktuelle News zur LIFETECH SCIENTIFIC Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
DoLIFETECH SCI (01302): VOLUNTARY ANNOUNCEMENT - G-ILIAC TM PRO ILIAC ARTERY STENT GRAFT SYSTEM OBTAINED OFFICIAL REGISTRATION APPROVAL FROM THE CHINA NMPA2
09.12.25LIFETECH SCI (01302): CONNECTED TRANSACTION - SHARE PURCHASE PURSUANT TO SHARE AWARD SCHEME1
21.11.25LIFETECH SCI (01302): LIST OF DIRECTORS AND THEIR ROLES AND FUNCTIONS3
21.11.25LIFETECH SCI (01302): CHANGE OF DIRECTORS AND COMPOSITION OF BOARD COMMITTEES1
LIFETECH SCIENTIFIC Aktie jetzt für 0€ handeln
06.11.25LIFETECH SCI (01302): VOLUNTARY ANNOUNCEMENT - G-BRANCH TM THORACOABDOMINAL ARTERY STENT GRAFT SYSTEM OBTAINED OFFICIAL REGISTRATION APPROVAL FROM THE ...-
29.10.25LIFETECH SCI (01302): VOLUNTARY ANNOUNCEMENT - PUBLICATION OF THE TWO-YEAR FOLLOW-UP RESULTS OF PHASE II CLINICAL STUDY AND PHASE III CLINICAL STUDY OF ...-
10.09.25LIFETECH SCI (01302): NOTIFICATION LETTER AND REQUEST FORM FOR NON-REGISTERED SHAREHOLDERS1
10.09.25LIFETECH SCI (01302): NOTIFICATION LETTER AND REPLY FORM FOR REGISTERED SHAREHOLDERS3
10.09.25LIFETECH SCI (01302): INTERIM REPORT 20251
29.08.25LifeTech Scientific Corporation reports 1H results1
29.08.25LifeTech Scientific Corporation Announces 2025 Interim Results: Core Business Demonstrated Resilience, Domestic and Overseas Sales Both Increased170HONG KONG, Aug. 29, 2025 /PRNewswire/ -- LifeTech Scientific Corporation ("LifeTech" or the "Company", together with its subsidiaries, the "Group", stock code:...
► Artikel lesen
29.08.25LIFETECH SCI (01302): INTERIM RESULTS ANNOUNCEMENT FOR THE SIX MONTHS ENDED 30 JUNE 20251
22.08.25LIFETECH SCI (01302): VOLUNTARY ANNOUNCEMENT - ADMISSION OF INNOVATIVE MEDICAL DEVICES IN RESPECT OF CONGENITAL HEART DEFECT OCCLUDER INTO SPECIAL EXAMINATION ...2
11.08.25LIFETECH SCI (01302): NOTICE OF BOARD MEETING1
28.03.25LifeTech Scientific Corporation Announced 2024 Annual Results: Revenue Exceeded RMB1.3 billion, and International Business Increased by 26%251SHENZHEN, China, March 28, 2025 /PRNewswire/ -- LifeTech Scientific Corporation (the "Company" or "LifeTech", Stock code: 1302.HK), a company specializing in...
► Artikel lesen
15 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1